Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26297 | 212 | 30.4 | 51% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
495 | 14696 | RADIATION RESEARCH//INTERNATIONAL JOURNAL OF RADIATION BIOLOGY//AMIFOSTINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TCD50 | Author keyword | 6 | 53% | 4% | 8 |
2 | REPOPULATION | Author keyword | 2 | 10% | 7% | 15 |
3 | R1H RHABDOMYOSARCOMA | Author keyword | 1 | 100% | 1% | 2 |
4 | TUMOR BED EFFECT | Author keyword | 1 | 33% | 1% | 3 |
5 | ALLGEMEINES KRANKENHAUS HAGEN | Address | 1 | 50% | 0% | 1 |
6 | ALTERNATIVE FRACTIONATION | Author keyword | 1 | 50% | 0% | 1 |
7 | ARBEITS WERPUNKT ALLGEMEINMED GESUNDHEITSSYST | Address | 1 | 50% | 0% | 1 |
8 | BONE MARROW REGENERATION | Author keyword | 1 | 50% | 0% | 1 |
9 | CLINICAL QUALITY MANAGEMENT | Author keyword | 1 | 50% | 0% | 1 |
10 | CLONOGEN | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TCD50 | 6 | 53% | 4% | 8 | Search TCD50 | Search TCD50 |
2 | REPOPULATION | 2 | 10% | 7% | 15 | Search REPOPULATION | Search REPOPULATION |
3 | R1H RHABDOMYOSARCOMA | 1 | 100% | 1% | 2 | Search R1H+RHABDOMYOSARCOMA | Search R1H+RHABDOMYOSARCOMA |
4 | TUMOR BED EFFECT | 1 | 33% | 1% | 3 | Search TUMOR+BED+EFFECT | Search TUMOR+BED+EFFECT |
5 | ALTERNATIVE FRACTIONATION | 1 | 50% | 0% | 1 | Search ALTERNATIVE+FRACTIONATION | Search ALTERNATIVE+FRACTIONATION |
6 | BONE MARROW REGENERATION | 1 | 50% | 0% | 1 | Search BONE+MARROW+REGENERATION | Search BONE+MARROW+REGENERATION |
7 | CLINICAL QUALITY MANAGEMENT | 1 | 50% | 0% | 1 | Search CLINICAL+QUALITY+MANAGEMENT | Search CLINICAL+QUALITY+MANAGEMENT |
8 | CLONOGEN | 1 | 50% | 0% | 1 | Search CLONOGEN | Search CLONOGEN |
9 | IN VIVO DOSE MEASUREMENT | 1 | 50% | 0% | 1 | Search IN+VIVO+DOSE+MEASUREMENT | Search IN+VIVO+DOSE+MEASUREMENT |
10 | RAT RHABDOMYOSARCOMA R1H | 1 | 50% | 0% | 1 | Search RAT+RHABDOMYOSARCOMA+R1H | Search RAT+RHABDOMYOSARCOMA+R1H |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | APPLICATORS LEIPZIG APPLICATOR | 8 | 100% | 2% | 5 |
2 | INTERSTITIAL HDR BRACHYTHERAPY | 8 | 100% | 2% | 5 |
3 | MAGNETIC RESONANCE SYSTEM | 8 | 100% | 2% | 5 |
4 | RADIOTHERAPY TREATMENT SIMULATION | 8 | 100% | 2% | 5 |
5 | BED STROMA | 6 | 71% | 2% | 5 |
6 | RHABDOMYOSARCOMA R1H | 4 | 40% | 4% | 8 |
7 | RADIATION INDUCED INJURY | 2 | 22% | 4% | 9 |
8 | RADIATION RELATED MORBIDITY | 2 | 50% | 1% | 3 |
9 | NCR SED NUDE MICE | 2 | 43% | 1% | 3 |
10 | FSA II | 1 | 50% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cancer stem cells at the crossroads of current cancer therapy failures Radiation oncology perspective | 2010 | 36 | 142 | 10% |
Multiple significance testing and its relevance for interpretation of results. Audit of the Journal "Strahlentherapie und Onkologie" | 2000 | 5 | 166 | 11% |
Actuarial analysis of time-failure data and its relevance for interpretation of results. Audit of the Journal "Strahlentherapie und onkologie" | 2000 | 2 | 171 | 11% |
Authorship in scientific publications. Audit of the Journal "Strahlentherapie and Onkologie" | 2001 | 1 | 149 | 11% |
Confidence intervals and their relevance for interpretation of results. Audit of the journal "Strahlentherapie und Onkologie" | 2000 | 1 | 168 | 11% |
Citation in scientific publications. Audit of the Journal "Strahlentherapie und Onkologie" | 2001 | 0 | 149 | 11% |
Nanoparticles: A Promising Modality in the Treatment of Sarcomas | 2011 | 2 | 121 | 2% |
Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells | 2001 | 22 | 76 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALLGEMEINES KRANKENHAUS HAGEN | 1 | 50% | 0.5% | 1 |
2 | ARBEITS WERPUNKT ALLGEMEINMED GESUNDHEITSSYST | 1 | 50% | 0.5% | 1 |
3 | MASSACHUSETTS GEN HOSP MED RADIAT MED | 1 | 50% | 0.5% | 1 |
4 | BIOPHYS STRAHLENBIOL | 1 | 12% | 2.4% | 5 |
5 | ABT RADIOONKOL STRAHLENTHER IE | 0 | 14% | 1.4% | 3 |
6 | ABT KLIN RADIOL WERPUNKT STRAHLENTHER IE | 0 | 33% | 0.5% | 1 |
7 | KLIN ORL | 0 | 33% | 0.5% | 1 |
8 | OCCUPAT HLTH RISK ASSESSMENT | 0 | 33% | 0.5% | 1 |
9 | SURG ONCOL VASC SURG | 0 | 25% | 0.5% | 1 |
10 | UNIV CANC D DEN | 0 | 20% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000248630 | HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP |
2 | 0.0000226993 | RADIATION MYELOPATHY//LINEAR QUADRATIC MODEL//EXPT ZENTRUM |
3 | 0.0000223380 | FRACTIONATED X IRRADIATION//RAT YOLK SAC TUMOR//DRUG EFFECT ON BRAIN |
4 | 0.0000164360 | PREDICTIVE ASSAYS//INDIVIDUAL RADIOSENSITIVITY//NORMAL TISSUE RESPONSE |
5 | 0.0000133662 | CARBOGEN//TUMOR HYPOXIA//TUMOR OXYGENATION |
6 | 0.0000111623 | LOW DOSE HYPER RADIOSENSITIVITY//HYPER RADIOSENSITIVITY//ULTRAFRACTIONATION |
7 | 0.0000096128 | POTENTIAL DOUBLING TIME//BROMODEOXYURIDINE//IODODEOXYURIDINE |
8 | 0.0000088429 | CELL AND TISSUE KINETICS//CELL TUMOUR BIOL//H 3 DT |
9 | 0.0000087029 | HEAD AND NECK CANCER//INDUCTION CHEMOTHERAPY//LOCALLY ADVANCED HEAD AND NECK CANCER |
10 | 0.0000076156 | MICROPROTEIN ASSAY//BIOLOGICAL MONITORING GUIDANCE VALUES//HUMAN CELLS IN VITRO |